HOME >> BIOLOGY >> NEWS
Dark Honey Has More Illness-Fighting Agents Than Light Honey

CHAMPAIGN, Ill. - Honey bees pollinate the crops we eat and provide honey. Where they forage for nectar now has gained nutritional importance: What they eat determines the level of antioxidants in honey, according to new research.

In a study that analyzed 19 samples of honey from 14 different floral sources, University of Illinois scientists found that honey made from nectar collected from Illinois buckwheat flowers packs 20 times the antioxidant punch as that produced by bees that lap up California sage. Clover, perhaps the most common plant source tapped by honey bees, scored in the middle of the rankings.

Antioxidants -- substances that slow the oxidation of other substances -- counter the toxic effects of free radicals, which can cause DNA damage that can lead to age-related problems such as arthritis, strokes and cancer. Free radicals are atoms or molecules that are usually reactive or unstable.

In an article to be published in the Journal of Apicultural Research, the researchers say darker honey has less water and more antioxidants than light-colored honey.

The co-authors of the study -- funded by the Illinois Value-Added Research Program and National Honey Board -- were May Berenbaum, head of the University of Illinois entomology department; Gene E. Robinson, director of the U. of I. bee research facility; and plant biology graduate student Steven M. Frankel.

"Not all honeys are the same," said Berenbaum, who also is a researcher in the U. of I. Functional Foods for Health program. "The antioxidant content of buckwheat honey compares favorably, pretty much bite for bite, with the ascorbic acid-related antioxidant content of tomatoes. Gram for gram, antioxidants in buckwheat honey equal that of fruits and vegetables such as sweet corn or tomatoes. It packs the antioxidant power of Vitamin C in a tomato, but most people who would be willing to eat an
'"/>

Contact: Jim Barlow
b-james3@uiuc.edu
217-333-5802
University of Illinois at Urbana-Champaign
6-Jul-1998


Page: 1 2

Related biology news :

1. Honey bee genome assembled
2. Honeybee gene find ends 150-year search
3. Honey bee genome being sequenced
4. Honey the darker the better Has potential as dietary antioxidant
5. USDA establishes Honeybee Genetics and IPM Center
6. Honey shines in athletic research, has scientific community abuzz
7. Honey as healer
8. Honey : Naturess sweetener may increase recuperation after workouts
9. Honey may be the ideal pre-workout energy source
10. Honey in the medicine cabinet!
11. Summer Science: Where Have All The Honeybees Gone? UD Bee Guy Asks Why--From America To The Amazon

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Dark Honey Has More Illness Fighting Agents Than Light Honey

(Date:8/26/2015)... 26, 2015 The report "Multi-Factor Authentication ... Factor), Application (Travel & Immigration, Government, Banking, Defense, Commercial ... to 2020", published by MarketsandMarkets, Multi-Factor Authentication Market is ... at a CAGR of 17.7% between 2015 and 2020. ... igures spread through 169 P ...
(Date:8/24/2015)... CAPE TOWN, South Africa , August 24, 2015 /PRNewswire/ ... awarded Germany ,s largest biometrics manufacturer DERMALOG ... with the "2015 African Biometrics Company of the ... installation in Nigeria .   ... ) and http://www.presseportal.de/nr/8896 - On Thursday ...
(Date:8/20/2015)... , Aug. 20, 2015 The wearable ... that are active and healthy. However, wearable technology ... hospital environment to help improve diagnostic capabilities and ... from the Wearable Technologies Conference 2015 , ... applications for wearables in healthcare.    ...
Breaking Biology News(10 mins):Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 2Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 3Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 4Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 5Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 2Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 3Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 2Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 3
(Date:8/27/2015)... ... August 27, 2015 , ... Inc. Magazine released its annual ... Solutions as number 1,361 in growth for the three years through 2014. Being named ... fastest-growing privately held organizations in the country. , “We are thrilled to make ...
(Date:8/27/2015)... ... August 27, 2015 , ... ... recently presented new data on the relationship of genetics and hypertension at the ... on Heart Disease in Vancouver, British Columbia, Canada. The event, which boasts an ...
(Date:8/26/2015)... , Aug. 26, 2015  Roka Bioscience, Inc. (NASDAQ: ... providing advanced testing solutions for the detection of foodborne ... present at the Sidoti & Company Emerging Growth Conference ... be held at the New York Marriott Marquis. ... be available through the investor relations section of Roka ...
(Date:8/26/2015)... 26, 2015  Platform therapeutic company Symic Biomedical, ... a $1.5M Phase II SBIR grant from the ... its therapeutic agent to reduce arteriovenous fistula (AVF) ... stage renal disease (ESRD) patients undergoing hemodialysis. The ... Diabetes and Digestive and Kidney Diseases (NIDDK), will ...
Breaking Biology Technology:iLab Solutions Named to 2015 Inc. 5000 List 2iLab Solutions Named to 2015 Inc. 5000 List 3Proove Biosciences Presents Ground-Breaking Data on Genetics and Heart Disease at 20th World Congress on Heart Disease 2Proove Biosciences Presents Ground-Breaking Data on Genetics and Heart Disease at 20th World Congress on Heart Disease 3Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 2Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 3
Cached News: